Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Apr 1:2018:5308491.
doi: 10.1155/2018/5308491. eCollection 2018.

Clinimetrics of the 9- and 19-Item Wearing-Off Questionnaire: A Systematic Review

Carlos E Mantese  1   2 , Artur Schumacher-Schuh  1 , Carlos R M Rieder  1   3   4
Affiliations
Review

Clinimetrics of the 9- and 19-Item Wearing-Off Questionnaire: A Systematic Review

Carlos E Mantese et al. Parkinsons Dis. .

Abstract

The treatment of Parkinson's disease (PD) with dopaminergic therapy improves functionality and quality of life. However, as the disease progresses, the wearing-off phenomenon develops, which necessitates complex posology adjustment or adjuvant therapy. This phenomenon may not be well recognized, especially if it is mild or involves nonmotor symptoms. Questionnaires were developed to improve the recognition of the wearing-off phenomenon. The questionnaires consist of a list of symptoms that patients must check if they have and if the symptoms improve with medication. A recent review by the Movement Disorder Society suggested the 19-item (WOQ-19) and 9-item (WOQ-9) questionnaires as screening tools for the wearing-off phenomenon. However, there has not been a systematic review to assess the questionnaires' clinimetric properties, such as sensitivity, specificity, test-retest reliability, and responsiveness. We conducted an extensive search for studies using these two tools. We identified 3 studies using WOQ-19 and 5 studies using WOQ-9. Both questionnaires seem to have good sensitivity (0.81-1). WOQ-19 has variable specificity (0.39-0.8), depending on the number of positive items, while WOQ-9 lacks specificity (0.1-0.69). Only one study using WOQ-19 reported test-retest, and only two studies reported responsiveness. Thus, this report describes the first independent systematic review to exam quantitatively the clinimetric properties of these two questionnaires.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram for data extraction.
See this image and copyright information in PMC

References

    1. Aquino C. C., Fox S. H. Clinical spectrum of levodopa-induced complications. Movement Disorders. 2015;30(1):80–89. doi: 10.1002/mds.26125. - DOI - PubMed
    1. Pahwa R., Lyons K. E. Levodopa-related wearing-off in Parkinson’s disease: identification and management. Current Medical Research and Opinion. 2009;25(4):841–849. doi: 10.1185/03007990902779319. - DOI - PubMed
    1. Stacy M., Bowron A., Guttman M., et al. Identification of motor and nonmotor wearing-off in Parkinson’s disease: comparison of a patient questionnaire versus a clinician assessment. Movement Disorders. 2005;20(6):726–733. doi: 10.1002/mds.20383. - DOI - PubMed
    1. Stacy M., Hauser R. Development of a patient questionnaire to facilitate recognition of motor and non-motor wearing-off in Parkinson’s disease. Journal of Neural Transmission. 2007;114(2):211–217. doi: 10.1007/s00702-006-0554-y. - DOI - PubMed
    1. Stacy M., Hauser R., Oertel W., et al. End-of-dose wearing off in Parkinson disease: a 9-question survey assessment. Clinical Neuropharmacology. 2006;29(6):312–321. doi: 10.1097/01.wnf.0000232277.68501.08. - DOI - PubMed

LinkOut - more resources